Sickle cell disease as an accelerated aging syndrome

Area of Science:

• Hematology
• Gerontology
• Pathophysiology

Background:

• Sickle cell disease (SCD) involves vaso-occlusion and hemolysis, leading to significant morbidity, mortality, and reduced quality of life.
• Normal aging involves cellular changes like sphingolipid abnormalities and telomere shortening, impacting physical fitness and disease susceptibility.

Purpose of the Study:

• To draw parallels between the manifestations of sickle cell disease and accelerated aging syndromes.
• To highlight how SCD impacts various organ systems, mirroring age-related changes.

Main Methods:

• This review synthesizes existing literature on SCD pathophysiology and normal aging processes.
• It compares cellular, organ-level, and physical manifestations observed in both conditions.

Main Results:

• Sickle erythrocytes exhibit features of aged cells, leading to premature destruction.
• SCD patients display accelerated aging in the brain, kidneys, heart, immune, and musculoskeletal systems.
• Common SCD complications like stroke, heart failure, and osteoporosis resemble those seen in the elderly.

Conclusions:

• Sickle cell disease can be viewed as an accelerated aging syndrome.
• Understanding these parallels can inform clinical management and research for SCD patients.